Valeant Raises Salix Bid, Agree To All-Cash Deal

By: via Benzinga
Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has raised its bid for Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) to $173 per share from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.